Abstract
Autoinflammatory diseases are a genetically heterogeneous group of rheumatologic diseases that are driven by abnormal activation of the innate immune system. Patients present with recurrent episodes of systemic inflammation and a spectrum of organ-specific comorbidities. These diseases are mediated by the overproduction of various inflammatory cytokines, such as IL-1, IL-18, IL-6, TNFα, and type I interferon. Treatments with biologic agents that inhibit these cytokines have been very efficient in most patients. During the past 2 years, remarkable progress has been made in the identification of disease-associated genes owing mostly to new technologies. Next generation sequencing technologies (NGS) have become instrumental in finding single-gene defects in undiagnosed patients with early onset symptoms. NGS has advanced the field of autoinflammation by identifying disease-causing genes that point to pathways not known to regulate cytokine signaling or inflammation. They include a protein that has a role in differentiation of myeloid cells, a ubiquitously expressed enzyme that catalyzes the addition of the CCA terminus to the 3-prime end of tRNA precursors, and an enzyme that catalyzes the oxidation of a broad range of substrates. Lastly, newly described mutations have informed a whole new dimension on genotype-phenotype relationships. Mutations in the same gene can give rise to a range of phenotypes with a common inflammatory component. This suggests greater than anticipated contributions by modifying alleles and environmental factors to disease expressivity.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00281-015-0478-4/MediaObjects/281_2015_478_Fig1_HTML.gif)
Similar content being viewed by others
References
Ombrello MJ, Sikora KA, Kastner DL (2014) Genetics, genomics, and their relevance to pathology and therapy. Best Pract Res Clin Rheumatol 28:175–189
Zhou Q et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920
Navon Elkan P et al (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921–931
Garg N et al (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173:827–830
van Montfrans J, Zavialov A, Zhou Q (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478
Van Eyck L, Liston A, Meyts I (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478–479
Bras J, Guerreiro R, Santo GC (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478–480
Van Eyck L, Liston A, Wouters C (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:480
Zavialov AV, Yu X, Spillmann D, Lauvau G, Zavialov AV (2010) Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem 285:12367–12377
Iijima R et al (2008) The extracellular adenosine deaminase growth factor, ADGF/CECR1, plays a role in Xenopus embryogenesis via the adenosine/P1 receptor. J Biol Chem 283:2255–2264
Dolezal T, Dolezelova E, Zurovec M, Bryant PJ (2005) A role for adenosine deaminase in Drosophila larval development. PLoS Biol 3:e201
Zavialov AV et al (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 88:279–290
Belot A et al (2014) Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J 12:44
Van Eyck L Jr et al (2015) Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135:283–287, e5
Liu Y et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507–518
Jeremiah N et al (2014) Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest 124:5516–5520
Burdette DL et al (2011) STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515–518
Barber GN (2014) STING-dependent cytosolic DNA sensing pathways. Trends Immunol 35:88–93
Burdette DL, Vance RE (2013) STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 14:19–26
Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674–678
Zhang L et al (2014) NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity 40:329–341
Boyce BF, **ng L (2007) The RANKL/RANK/OPG pathway. Curr Osteoporos Rep 5:98–104
Walsh MC, Choi Y (2014) Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol 5:511
Soysa NS, Alles N, Aoki K, Ohya K (2012) Osteoclast formation and differentiation: an overview. J Med Dent Sci 59:65–74
Whyte MP (2006) Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. Ann N Y Acad Sci 1068:143–164
Hanada R et al (2009) Central control of fever and female body temperature by RANKL/RANK. Nature 462:505–509
Jeru I et al (2014) Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders. Arthritis Rheumatol 66:2621–2627
Anderson DM et al (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175–179
Dougall WC et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412–2424
Canna SW et al (2014) An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46:1140–1146
Romberg N et al (2014) Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 46:1135–1139
Kitamura A, Sasaki Y, Abe T, Kano H, Yasutomo K (2014) An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med 211:2385–2396
Franchi L et al (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:576–582
Vance RE (2015) The NAIP/NLRC4 inflammasomes. Curr Opin Immunol 32C:84–89
Sellin ME et al (2014) Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe 16:237–248
Zhao Y et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596–600
Nordlander S, Pott J, Maloy KJ (2014) NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol 7:775–785
Wiseman DH et al (2013) A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood 122:112–123
Chakraborty PK et al (2014) Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). Blood 124:2867–2871
Sasarman F, et al (2015) The 3' addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1. Hum Mol Genet
**ong Y, Steitz TA (2006) A story with a good ending: tRNA 3'-end maturation by CCA-adding enzymes. Curr Opin Struct Biol 16:12–17
Cimaz R, Von Scheven A, Hofer M (2012) Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease. Swiss Med Wkly 142:w13582
Pascual V et al (2008) How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev 223:39–59
Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479–1486
Wakil SM et al (2015) Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol 67:288–295
Wong SH, Hill AV, Vannberg FO, India-Africa-United Kingdom Leprosy Genetics, C (2010) Genomewide association study of leprosy. N Engl J Med 362:1446–7, author reply 1447-8
Zhang FR et al (2009) Genomewide association study of leprosy. N Engl J Med 361:2609–2618
Sales-Marques C et al (2014) NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians. Hum Genet 133:1525–1532
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is a contribution to the Special Issue on The Inflammasome and Autoinflammatory Diseases - Guest Editors: Seth L. Masters, Tilmann Kallinich and Seza Ozen
Rights and permissions
About this article
Cite this article
Aksentijevich, I. Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years. Semin Immunopathol 37, 395–401 (2015). https://doi.org/10.1007/s00281-015-0478-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-015-0478-4